# Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia

> **NCT00188084** · — · UNKNOWN · sponsor: **University Hospital, Angers** · enrollment: 400 (—)

## Conditions studied

- Adult Acute Lymphoblastic Leukemia

## Interventions

- **PROCEDURE:** DNA Index
- **PROCEDURE:** S-Phase%
- **PROCEDURE:** CD45 expression
- **PROCEDURE:** P16 metabolic way

## Key facts

- **NCT ID:** NCT00188084
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 400 (—)
- **Last updated:** 2005-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00188084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00188084, "Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00188084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*